Jubilant Biosys and Yale University announce collaboration to accelerate multiple small molecule discovery programs
News provided by
Share this article
Share this article
NEW HAVEN, Conn. and BENGALURU, India, Feb. 9, 2021 /PRNewswire/ Today, Jubilant Biosys and Yale University have announced a research collaboration for multiple small molecule research programs.
Under the scope of this partnership, Jubilant Biosys will provide research services to investigators at Yale University working on novel therapeutic targets. Areas of collaboration include medicinal chemistry, structural biology, in-vitro and in-vivo pharmacology among others.
Yale Logo
Commenting on this collaboration, Marcel Velterop, President Jubilant Biosys said
Yale is one of the top-ranked academic institutions in the US and we at Jubilant Biosys are delighted to be able to support scientific endeavours of Investigators at Yale to pursue novel target ideas for unmet medical conditions. With our New Discove